Organization type


  • Biotech
  • Consultancy firm
  • Service provider

Early phases


  • Omics
    • Genomics
    • Metabolomics
  • Target identification – new biological hypothesis

Screening


  • Fragment based screening
    • Virtual screening

Optimization phases


  • Medicinal chemistry programs for hit to lead and lead optimization
  • Preclinical phase (including assay/model development and testing)(non-regulatory and regulatory)
    • ADME / DMPK
    • Safety
    • Toxicology

Functional areas


  • Artificial intelligence
  • Bioinformatics

Terapeutic areas


  • Autoimmunity / Inflammation
  • Blood and lymphatic system
  • Cancer
  • Cardiovascular
  • Dermatology
  • Infectious diseases
  • Metabolism / Endocrinology
  • Nervous Central System
  • Ophthalmology / Optometry
  • Rare diseases

Additional activities


  • Consulting services